NDC 81033-035-06 - TOPIRAMATE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 81033-035
- Requested NDC
- 81033-035-06
- Package NDCs from labels
- 81033-035-04, 81033-035-14, 81033-035-06, 81033-035-15, 81033-035-08, 81033-035-16
- Manufacturer
- Kesin Pharma
- Effective date
- 2026-06-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| TOPIRAMATE - Kesin Pharma | Kesin Pharma | 2026-06-16 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Oasis Tears PF Preservative-Free Lubricant Eye | GLYCERIN | OASIS Medical, Inc. | 640f95f4-c2e8-48ad-ad40-f76bbaddb0dc | 2025-09-12 | Warnings | PDC6A3C0OX |
| Oasis TEARS PF PLUS Preservative-Free Lubricant Eye | GLYCERIN | OASIS Medical, Inc. | 5d080191-423d-4c0a-b5ae-2ccf5c4a67cb | 2025-09-08 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Rising Pharma Holdings, Inc. | db539b39-9504-44d2-9bd5-ba6ffb441024 | 2025-09-08 | Warnings | PDC6A3C0OX |
| Glycerin Children | GLYCERIN | Rising Pharma Holdings, Inc. | 80a5a944-2882-4f8d-a955-ef827cead5f0 | 2025-09-08 | Warnings | PDC6A3C0OX |
| topiramate | TOPIRAMATE | Major Pharmaceuticals | 6fb00bd8-c49e-46ef-9d6b-1b602e1d11d8 | 2025-08-25 | Warnings, Adverse reactions | 0H73WJJ391 |
| Foaming Facial Cleanser | GLYCERIN, NIACINAMIDE | Guangzhou Danting Bath&Body Care Industry Co. Ltd | 396c1db9-a5d3-cc82-e063-6294a90a90bb | 2025-08-23 | Warnings | PDC6A3C0OX |
| Refresh RELIEVA PF | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | Allergan, Inc. | d5d3df4a-a311-4f2d-9a24-edfec1a6c9f9 | 2025-08-22 | Warnings | PDC6A3C0OX |
| Refresh Optive | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN | Allergan, Inc. | 37e99aa8-02d6-4efb-a862-90bc7fcd5ca5 | 2025-08-22 | Warnings | PDC6A3C0OX |
| Upside Down Pain Relief | BENZOCAINE, GLYCERIN | Fridababy, LLC | 31c2cd25-1fec-5ec5-e063-6394a90a24b4 | 2025-08-15 | Warnings | PDC6A3C0OX |
| topiramate | TOPIRAMATE | A-S Medication Solutions | 674c2c2e-014a-43a1-91a7-7214ffc4b1d7 | 2025-08-13 | Warnings, Adverse reactions | 0H73WJJ391 |
| Norms Hemorrhoid | GLYCERIN, LIDOCAINE, PETROLATUM, PHENYLEPHRINE HCL | Totally Normal Company | 3bdf8c74-3db6-1805-e063-6394a90aaba0 | 2025-08-08 | Warnings | PDC6A3C0OX |
| Systane COMPLETE | PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 2df0de02-a3e2-471a-9e10-040c3fba75fe | 2025-08-08 | Warnings | 6DC9Q167V3 |
| Durma DynaGel | DURMA DYNAGEL | Dynarex Corporation | 3bcbe314-98ca-78f1-e063-6394a90a13ad | 2025-08-07 | Warnings | PDC6A3C0OX |
| Medics Choice Fresh and Soothe | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN | Unimed | 3bcd8394-f486-d306-e063-6294a90a4e9a | 2025-08-07 | Warnings | PDC6A3C0OX |
| Systane Balance | PROPYLENE GLYCOL | Alcon Laboratories, Inc. | c7b1a03a-a5f2-409e-a34a-d6f166671de5 | 2025-08-07 | Warnings | 6DC9Q167V3 |
| Medics Choice Fresh and Soothe | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN | KC Pharmaceuticals, Inc. | 3bc03d54-6b31-5921-e063-6294a90af599 | 2025-08-01 | Warnings | PDC6A3C0OX |
| Systane Ultra | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 0537c23a-15f7-be64-1231-a6c93468e9a8 | 2025-07-30 | Warnings | 6DC9Q167V3 B697894SGQ |
| Systane | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 1d679d0f-cec2-a644-79cd-079607254bb9 | 2025-07-30 | Warnings | 6DC9Q167V3 B697894SGQ |
| Systane Ultra Preservative Free | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 751fb85f-6683-4b0a-a650-324d4a74c5de | 2025-07-30 | Warnings | 6DC9Q167V3 B697894SGQ |
| Systane COMPLETE PF | PROPYLENE GLYCOL | Alcon Laboratories, Inc. | 99b63d62-1cf0-4f28-8760-773917c2538a | 2025-07-29 | Warnings | 6DC9Q167V3 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.